COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 1342: Articles 13411-13420  | Next

Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19
Chudzik, M., Kapusta, J., Burzynska, M.
10.1101/2021.07.14.21259081 — Posted: 2021-07-14
Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cells
Lemieux, J. E., Li, A., Gentili, M., Perugino, C. A., Weiss, Z. F., Bowman, K., Ankomah, P., Liu, H., Lewis, G. D., Bitar, N., Lipiner, T., Hacohen, N., Pillai, S. S., Goldberg, M. B.
10.1101/2021.07.11.21260338 — Posted: 2021-07-14
SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients
Vacharathit, V., Aiewsakun, P., Manopwisedjaroen, S., Srisaowakarn, C., Laopanupong, T., Ludowyke, N., Phuphuakrat, A., Setthaudom, C., Ekronarongchai, S., Srichatrapimuk, S., Wongsirisin, P., Sangrajrang, S., Imsuwansri, T., Kirdlarp, S., Nualkaew, S., Sensorn, I., Sawaengdee, W., Wichukchinda, N., Sungkanuparph, S., Chantratita, W., Kunakorn, M., Rojanamatin, J., Hongeng, S., Thitithanyanont, A.
10.1101/2021.07.10.21260232 — Posted: 2021-07-14 Discussion: Onsite
Comparison of humoral and cellular responses in kidney transplant recipients receiving BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines
Prendecki, M., Thomson, T., Clarke, C. L., Martin, P., Gleeson, S., De aguiar, R. c., Edwards, H., Mortimer, P., McIntyre, S., Lewis, S., Deborah, J., Cox, A., Pickard, G., Lightstone, L., McAdoo, S. P., Kelleher, P., Willicombe, M., OCTAVE Study Consortium
10.1101/2021.07.09.21260192 — Posted: 2021-07-14
COVID-19 vaccine hesitancy in the UK: A longitudinal household cross-sectional study
Chaudhuri, K., Chakrabarti, A., Chandan, J. S., Bandyopadhyay, S.
10.1101/2021.07.09.21260206 — Posted: 2021-07-14
STUDY OF BLOOD GROUP ANALYSIS AND ITS CORRELATION WITH LYMPHOPENIA IN COVID 19 INFECTED CASES OUR EXPERIENCE IN TERITARY CARE HOSPITAL.
Ravuri, S. G., Ravuri, S., Cigiri, S., Kalangi, H., Jeshtadi, A., Kumar, N. K., Bacchu, S., Nampally, V. K.
10.1101/2021.07.12.21258824 — Posted: 2021-07-14
Using population based Kalman estimator to model COVID-19 epidemics in France: estimating the burden of SARS-CoV-2 and the effects of NPI.
Collin, A., Hejblum, B., Vignals, C., Lehot, L., Thiebaut, R., Moireau, P., Prague, M.
10.1101/2021.07.09.21260259 — Posted: 2021-07-14
Mapping First to Second wave transition of covid19 Indian data via Sigmoid function and prediction of Third wave
MONDAL, S., Ghosh, S.
10.1101/2021.07.11.21260325 — Posted: 2021-07-14
ONLINE QUERIES AS A CRITERION FOR EVALUATION OF THE EPIDEMIOLOGICAL STATUS AND EFFECTIVENESS OF COVID-19 EPIDEMIC CONTROL MEASURES
Momynaliev, K., Khoroshun, D., Akimkin, V.
10.1101/2021.07.11.21260148 — Posted: 2021-07-14
Plasma P-selectin is an early marker of thromboembolism in COVID-19
Fenyves, B. G., Mehta, A., MGH COVID-19 Collection & Processing Team, , Kays, K., Goldberg, M., Hacohen, N., Filbin, M.
10.1101/2021.07.10.21260293 — Posted: 2021-07-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).